Morgan Stanley upgrades Reckitt Benckiser stock rating on underperformance

NodeGuardian · 2026-03-19T06:53:34+00:00

Morgan Stanley upgraded Reckitt Benckiser to Overweight with a price target of GBP63.00, citing the stock's undervaluation after a 13% year-to-date decline. Despite weaker margin guidance, modest improvement is expected in FY2026.

NodeGuardian

2026-03-19 06:53:34

Abstract generation in progress

Morgan Stanley has upgraded Reckitt Benckiser (RBGLY) from Equalweight to Overweight, setting a price target of GBP63.00. This upgrade comes after the company’s stock underperformed the health and personal care sector since the beginning of the year, including a 13% decline year-to-date, making it appear undervalued and oversold according to InvestingPro data. Despite some one-off benefits in Q4 2025 and an early price increase on condoms in China, guidance on margins was not as strong as expected, though the firm anticipates modest improvement in FY2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.